SCHEMBL24815919

SCHEMBL24815919

NC(CCCCCCc1ccc(C(F)(F)F)cc1)C(=O)O

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 1/20 0.51
HDAC8 Q9BY41 1/20 0.51
GRM8 O00222 1/20 0.50
GRM4 Q14833 1/20 0.50
GRB2 P62993 1/20 0.49
KIF11 P52732 2/20 0.48
PTPN1 P18031 2/20 0.46
NOS1 P29475 2/20 0.45
FDFT1 P37268 2/20 0.45
TAAR1 Q96RJ0 1/20 0.45
GRIK1 P39086 2/20 0.44
GRIK2 Q13002 1/20 0.44
POLB P06746 1/20 0.43
KMT2A Q03164 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
PTPN2 P17706 1/20 0.43
PTPN6 P29350 1/20 0.43
PTPN11 Q06124 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16542431 0.94 GRM8 (0.52) HDAC1HDAC8GRM8GRM4GRB2
SCHEMBL25183013 0.94 GRM8 (0.52) HDAC1HDAC8GRM8GRM4GRB2
SCHEMBL21553586 0.88 GRM8 (0.55) HDAC1HDAC8GRM8GRM4GRB2
SCHEMBL22444936 0.88 GRM8 (0.55) HDAC1HDAC8GRM8GRM4GRB2
SCHEMBL10419950 0.83 HDAC1 (0.53) HDAC1HDAC8KIF11TAAR1
SCHEMBL27734494 0.82 FDFT1 (0.50) HDAC1HDAC8GRB2KIF11PTPN1
SCHEMBL27734496 0.82 FDFT1 (0.50) HDAC1HDAC8GRB2KIF11PTPN1
SCHEMBL23176817 0.81 GRIK1 (0.64) KIF11NOS1GRIK1POLBKMT2A
SCHEMBL24816430 0.81 GRIK1 (0.64) KIF11NOS1GRIK1POLBKMT2A
SCHEMBL17686507 0.81 GRIK1 (0.64) KIF11NOS1GRIK1POLBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220411362-A1 DITERPENOID COMPOUNDS THAT ACT ON PROTEIN KINASE C (PKC) K-GEN THERAPEUTICS, INC. 2022-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220411362-A1 DITERPENOID COMPOUNDS THAT ACT ON PROTEIN KINASE C (PKC) PRKCA, PRKCH, PRKCB HDAC1 1272/4885HDAC8 507/4885GRM8 2441/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.